About Coreline

We proudly say that we are one of the best in AI-imaging solutions for early detection and diagnosis of lung-related disease, including COPD quantification, lung cancer screening (LCS), and coronary artery calcification (CAC) systems, covering the entire field of Big 3 thoracic diseases.
To meet the increasing need in research field for quantification tools in ILD/IPF, AVIEW Lung Texture, a more in-depth of its texture analysis and pneumonia detection including COVID-19 is now available.

Our progress in EU

  • Coreline Soft Europe was established in Germany in 2020
  • RMS Medical Devices is our partner in the Benelux area
  • Our COPD systems are used by European customers such as UZ Leuven in Belgium, University of Leicester in the UK, and Parma University in Italy, receiving high evaluation on its reliability for early detection, pheonotyping, and surgery support.

Products

AVIEW COPD

Youtube
Brochure

AVIEW LCS PLUS

Youtube
Brochure

AVIEW CAC

Youtube
Brochure

AVIEW Modeler

Youtube
Brochure

COPD Quantification
including fissure measurement

  • Quantitatively evaluate fissure-integrity.
    (FIR: Fissure Integrity Ratio)
  • Useful for lung-volume reduction and surgery.
AVIEW COPD UI
Report (PDF)

Features

Emphysema

LAA Volume Ratio
LAA Size Analysis

Airway

Structure define & labeling
Airway diameter & wall thickness

Vessel

Pulmonary vessel segmentation
Vessel volume analysis

Air-trapping

Air trapping analysis
Joint-histogram analysis

Fissure Integrity

Completeness of fissure

AVIEW LCS PLUS
Lung Cancer Screening Plus

COPD
Lung Cancer
Coronary Artery Calcification

AVIEW Lung Cancer Screening (LCS) is a medical imaging AI software that provides automated lung nodule detection, segmentation, and analysis from Low-Dose CT chest images.

The Coreline LCS program has been the sole official solution selected from the ‘K-LUCAS’ (Korean Lung Cancer Screening) from its pilot project period of the YR 2017-2018 and its full-out screening YR 2019 till now.

Since 2019, with its full-out screening program, Coreline has been working with more than 300 hospitals (50 of which are connected to the ‘National Cloud’ with the Central Data repository system).

Big 3 thoracic diseases are;
  • Lung Cancer
  • COPD
  • CAC

We are the Official solution provider for:

  • The nationwide lung cancer screening program in Korea (K-Lucas) from 2017, which is the 2nd state-level-reimbursed LCS program following the US from 2015
  • 4-ITLR project by the Nelson Team (Erasmus MC and iDNA in the Netherlands), which is a large early detection LCS trial on LCS+ system. Two hospitals in Germany, DKFZ Heidelberg and University Hospital of Essen, are the members of this trial and our systems will be implemented in these hospitals from 2021
  • The German trial by multi-university hospitals which is a pilot project to prove the need for the national support for lung cancer screening in Germany

Features

Nodule AI CAD (CE, TFDA, KFDA Approved)

Computer-Aided Detection (CAD) for lung nodules
Zero waiting time by APS (Auto Processing Server)

Follow-up Mode

Current/ Previous study comparison by non-rigid registration
Nodule change information over time for all nodule types

Lung-RADS | Brock Score

Lung-RADS (Ver. 1.0 or 1.1)
Brock Score (aka, PANCAN Risk Model)

EUPS & VDT

Volume Doubling Time Calculation
EUPS(European Position Statement)

GSPS & DICOM SR

Seamless & Easy Integration
Compatible with various PACS

‘In-depth’ Access

Editing & Detailed Nodule Information out of PAC VIEWER
when user want to access it

Personal Contact

Sean LeeCBO
sean.lee@corelinesoft.com
Alice KimOverseas Manager
alice@corelinesoft.com
Chloe KimOverseas Manager
chloe.kim@corelinesoft.com